查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762365

腫瘤學的放射線治療市場，規模，佔有率，趨勢，產業分析報告:放射線類別，不同治療，各終端用戶，各地區，2025年～2034年的市場預測

Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2034年，全球腫瘤放射治療市場規模將達到154.3億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

腫瘤放射治療市場涵蓋使用高能量電離輻射治療和管理癌症。這種治療方式是將放射線精準地照射到惡性腫瘤，以消除或抑制癌細胞的生長，同時最大限度地減少對周圍健康組織和器官的損害。放射腫瘤學使用多種放射源和技術，包括使用直線加速器的體外放射治療 (EBRT)、使用置於體內的放射源的體內放射治療（近距離放射治療）以及使用在體內循環的放射性物質的全身照射。放射腫瘤學領域整合了先進的影像技術、治療計畫軟體和專業醫學知識，以優化不同腫瘤類型和分期患者的治療效果。

放射腫瘤學市場是更廣泛的放射腫瘤學領域中的一個重要領域，其發展受到全球癌症發病率上升和放射輸送技術不斷進步的推動。市場概況揭示了一個動態的環境，受個人化醫療的普及等因素影響，個人化醫療可根據個別患者和腫瘤特徵量身訂做放射治療。調強放射治療 (IMRT)、影像導引放射治療 (IGRT)、質子治療和磁振造影導引放射治療 (MRgRT) 等技術創新提高了治療的精確度和有效性，刺激了市場發展。此外，新興國家醫療基礎設施的不斷擴張以及對微創癌症治療方案日益增長的需求，也顯著促進了放射腫瘤學的整體市場成長和市場潛力。

腫瘤放射治療市場報告重點

按放射類型劃分，體外放射治療目前在全球佔據最高市場佔有率，因為它適用於多種癌症類型，且配備該技術的治療中心隨處可見。其非侵入性特性和完善的臨床方案使其成為放射治療市場的主導地位。

按治療類型劃分，調強放射治療 (IMRT) 目前佔據最大市場佔有率。這主要歸功於其先進的技術，能夠根據腫瘤形狀精確調整放射劑量，同時調節光束強度。 IMRT 已被廣泛應用於各種癌症治療，並已被證明可有效提高局部控制率。

以最終用戶劃分，醫院和醫學研究機構目前佔據最大市場佔有率。這主要是因為以放射治療為基本治療方法的醫院提供全面的癌症治療服務，且其治療的患者數量龐大，醫學研究機構也進行研究活動。

按地區劃分，北美目前在腫瘤放射治療市場中佔有最大的市場佔有率。預計在預測期內，亞太地區腫瘤放射治療市場的成長率最高。

目前活躍於腫瘤放射治療市場且尚未被收購的主要參與者包括 Accuray Incorporated、Elekta AB、Mevion Medical Systems、西門子醫療（包括瓦里安醫療系統）、IBA Worldwide、ViewRay Technologies Inc、Perspective Therapeutics Inc（前身為 Isoray Inc.）、日立蔡株（日立蔡株）子公司

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 腫瘤學的全球放射治療市場洞察

  • 市場概述
  • 腫瘤學市場動態
    • 促進因素和機會
      • 全球癌症發生率上升推動市場需求
      • 技術進步提升療效
    • 阻礙因素與課題
      • 放射設備成本高昂
  • PESTEL分析
  • 腫瘤學市場上放射治療的應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球腫瘤學的放射線治療市場:放射線類別

  • 主要調查結果
  • 簡介
  • 外部電子束照射
  • 內部電子束照射

第6章 全球腫瘤學的放射線治療市場:不同治療

  • 主要調查結果
  • 簡介
  • 定位放射線手術(SRS)
  • 影像導航放射治療(IGRT)
  • 強度調控放射治療(IMRT)
  • 體積調變電弧治療(VMAT)
  • 接近放射線治療

第7章 全球腫瘤學的放射線治療市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 醫院及醫療調查機關
  • 專門放射治療中心

第8章 全球腫瘤學的放射線治療市場:各地區

  • 主要調查結果
  • 簡介
    • 腫瘤學的放射線治療市場評估:各地區，2020-2034年
  • 北美
    • 北美:放射線類別，2020～2034年
    • 北美:不同治療，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:放射線類別，2020～2034年
    • 歐洲:不同治療，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:放射線類別，2020～2034年
    • 亞太地區:不同治療，2020～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:放射線類別，2020～2034年
    • 中東·非洲:不同治療，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:放射線類別，2020～2034年
    • 南美:不同治療，2020～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Accuray Incorporated
  • Carl Zeiss Meditec AG(a subsidiary of Carl Zeiss AG)
  • Elekta AB
  • Hitachi Ltd(part of Hitachi High-Tech Corporation)
  • IBA Worldwide
  • Mevion Medical Systems
  • Perspective Therapeutics Inc(formerly Isoray Inc)
  • Siemens Healthineers(which includes Varian Medical Systems)
  • Sumitomo Heavy Industries Ltd
  • ViewRay Technologies Inc
Product Code: PM5746

The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.

The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.

Radiation Therapy in the Oncology Market Report Highlights:

By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.

By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.

By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.

By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.

The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).

Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:

By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)

External Beam Radiation

Internal Beam Radiation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Stereotactic Radiosurgery (SRS)

Image-Guided Radiation Therapy (IGRT)

Intensity-Modulated Radiation Therapy (IMRT)

Volumetric-Modulated Arc Therapy (VMAT)

Brachytherapy

By End-User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Medical Research Institutes

Specialized Radiotherapy Centers

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Radiation Therapy in the Oncology Market Insights

  • 4.1. Radiation Therapy in the Oncology Market - Market Snapshot
  • 4.2. Radiation Therapy in the Oncology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Global Cancer Incidence Driving Market Demand
      • 4.2.1.2. Technological Advancements Enhancing Treatment Efficacy
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of radiation equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Radiation Therapy in the Oncology Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Radiation Therapy in the Oncology Market, by Radiation Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • 5.3. External Beam Radiation
    • 5.3.1. Global Radiation Therapy in the Oncology Market, by External Beam Radiation, by Region, 2020-2034 (USD Billion)
  • 5.4. Internal Beam Radiation
    • 5.4.1. Global Radiation Therapy in the Oncology Market, by Internal Beam Radiation, by Region, 2020-2034 (USD Billion)

6. Global Radiation Therapy in the Oncology Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • 6.3. Stereotactic Radiosurgery (SRS)
    • 6.3.1. Global Radiation Therapy in the Oncology Market, by Stereotactic Radiosurgery (SRS), by Region, 2020-2034 (USD Billion)
  • 6.4. Image-Guided Radiation Therapy (IGRT)
    • 6.4.1. Global Radiation Therapy in the Oncology Market, by Image-Guided Radiation Therapy (IGRT), by Region, 2020-2034 (USD Billion)
  • 6.5. Intensity-Modulated Radiation Therapy (IMRT)
    • 6.5.1. Global Radiation Therapy in the Oncology Market, by Intensity-Modulated Radiation Therapy (IMRT), by Region, 2020-2034 (USD Billion)
  • 6.6. Volumetric-Modulated Arc Therapy (VMAT)
    • 6.6.1. Global Radiation Therapy in the Oncology Market, by Volumetric-Modulated Arc Therapy (VMAT), by Region, 2020-2034 (USD Billion)
  • 6.7. Brachytherapy
    • 6.7.1. Global Radiation Therapy in the Oncology Market, by Brachytherapy, by Region, 2020-2034 (USD Billion)

7. Global Radiation Therapy in the Oncology Market, by End-User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Medical Research Institutes
    • 7.3.1. Global Radiation Therapy in the Oncology Market, by Hospitals & Medical Research Institutes, by Region, 2020-2034 (USD Billion)
  • 7.4. Specialized Radiotherapy Centers
    • 7.4.1. Global Radiation Therapy in the Oncology Market, by Specialized Radiotherapy Centers, by Region, 2020-2034 (USD Billion)

8. Global Radiation Therapy in the Oncology Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Radiation Therapy in the Oncology Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Radiation Therapy in the Oncology Market - North America
    • 8.3.1. North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.3.3. North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.3.4. Radiation Therapy in the Oncology Market - U.S.
      • 8.3.4.1. U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.3.5. Radiation Therapy in the Oncology Market - Canada
      • 8.3.5.1. Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.4. Radiation Therapy in the Oncology Market - Europe
    • 8.4.1. Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.4. Radiation Therapy in the Oncology Market - UK
      • 8.4.4.1. UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.5. Radiation Therapy in the Oncology Market - France
      • 8.4.5.1. France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.6. Radiation Therapy in the Oncology Market - Germany
      • 8.4.6.1. Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.7. Radiation Therapy in the Oncology Market - Italy
      • 8.4.7.1. Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.8. Radiation Therapy in the Oncology Market - Spain
      • 8.4.8.1. Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.9. Radiation Therapy in the Oncology Market - Netherlands
      • 8.4.9.1. Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.10. Radiation Therapy in the Oncology Market - Russia
      • 8.4.10.1. Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.4.11. Radiation Therapy in the Oncology Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.5. Radiation Therapy in the Oncology Market - Asia Pacific
    • 8.5.1. Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.4. Radiation Therapy in the Oncology Market - China
      • 8.5.4.1. China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.5. Radiation Therapy in the Oncology Market - India
      • 8.5.5.1. India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.6. Radiation Therapy in the Oncology Market - Malaysia
      • 8.5.6.1. Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.7. Radiation Therapy in the Oncology Market - Japan
      • 8.5.7.1. Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.8. Radiation Therapy in the Oncology Market - Indonesia
      • 8.5.8.1. Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.9. Radiation Therapy in the Oncology Market - South Korea
      • 8.5.9.1. South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.10. Radiation Therapy in the Oncology Market - Australia
      • 8.5.10.1. Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.5.11. Radiation Therapy in the Oncology Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.6. Radiation Therapy in the Oncology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.4. Radiation Therapy in the Oncology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.5. Radiation Therapy in the Oncology Market - UAE
      • 8.6.5.1. UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.6. Radiation Therapy in the Oncology Market - Israel
      • 8.6.6.1. Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.7. Radiation Therapy in the Oncology Market - South Africa
      • 8.6.7.1. South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.6.8. Radiation Therapy in the Oncology Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • 8.7. Radiation Therapy in the Oncology Market - Latin America
    • 8.7.1. Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.4. Radiation Therapy in the Oncology Market - Mexico
      • 8.7.4.1. Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.5. Radiation Therapy in the Oncology Market - Brazil
      • 8.7.5.1. Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.6. Radiation Therapy in the Oncology Market - Argentina
      • 8.7.6.1. Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
    • 8.7.7. Radiation Therapy in the Oncology Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Accuray Incorporated
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Elekta AB
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Hitachi Ltd (part of Hitachi High-Tech Corporation)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. IBA Worldwide
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Mevion Medical Systems
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Perspective Therapeutics Inc (formerly Isoray Inc)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Siemens Healthineers (which includes Varian Medical Systems)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sumitomo Heavy Industries Ltd
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ViewRay Technologies Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 2 Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 3 Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 4 North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 5 North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 6 North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 9 U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 10 Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 13 Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 15 Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 16 UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 17 UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 18 UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 19 France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 20 France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 21 France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 22 Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 24 Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 25 Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 28 Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 30 Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 34 Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 36 Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 43 China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 44 China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 45 China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 46 India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 47 India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 48 India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 52 Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 54 Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 60 South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 61 Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 63 Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 73 UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 75 UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 76 Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 78 Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 81 South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 90 Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 93 Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 96 Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Radiation Therapy in the Oncology Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Radiation Type
  • Figure 7. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Radiation Therapy in the Oncology Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End-User
  • Figure 11. Global Radiation Therapy in the Oncology Market, by End-User, 2024 & 2034 (USD Billion)